Himuka AM Pharma

Japan
Miyazaki, Miyazaki, Japan, 880-0812

Company profile

Himuka AM Pharma company profile

Himuka AM Pharma is a pharmaceutical company focusing on the development of Adrenomedullin derivatives. Himuka AM Pharma creates drug candidates based on the bioactive peptide adrenomedullin (AM), which was discovered at the University of Miyazaki (formerly Miyazaki Medical College). Their drug candidates will make significant contributions to the resolution of unmet medical needs.

Business identity

Contact email
[email protected]
Phone number
+81 0985-69-3287
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2017-02-01

Headquarters

Postal code
880-0812
Country code
JP
Continent
Asia

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$5.5M
Last funding
Corporate Round / 2018-06-20
Last equity funding
Corporate Round
Investors
9
Lead investors
1
Founders
1

Founders and investors

Founders

Araki Yuji

Lead investors

Japan Science and Technology Agency

Investors

Keio Innovation InitiativeMitsubishi UFJ CapitalMiyagin Venture CapitalMiyazaki Taiyo CapitalNippon Venture Capital